It is a modern, automated, molecular biology test that directly detects the presence of DNA of the Human Papillomavirus (HPV) virus – the main cause of more than 99% of cervical cancer cases.
Automated sample preparation machine for cytology samples (GYN and NonGYN). It is a specialized automated device for the preparation of liquid-based cytology (LBC) samples, approved by the KFDA for cancer screening tests, especially cervical cancer.
It is an immunocytochemistry assay used to screen for and aid in the early diagnosis of cervical cancer. This is an important step forward in the management of HPV-positive cases, helping to stratify the risk and provide appropriate treatment for patients.
Our solution provides an integrated testing platform that combines different modules to perform various types of tests on a single system. This optimizes space, minimizes manual sample handling, accelerates turnaround time, and improves overall laboratory effectiveness.
Our solution provides an integrated testing platform that combines different modules to perform various types of tests on a single system. This optimizes space, minimizes manual sample handling, accelerates turnaround time, and improves overall laboratory effectiveness.
We provide molecular diagnostic solutions featuring advanced technologies like real-time PCR. These solutions play a pivotal role in diagnosing viruses (HIV, HBV, HCV, HPV), bacteria, genetic testing, and molecular-level cancer diagnostics, thereby enabling individualized treatment for each patient.
We offer automated tissue staining systems and specialized reagents for cancer diagnostics, helping anatomical pathologists accurately identify cancer types and tumor biological characteristics. This is crucial for selecting targeted therapies and prognosticating the disease.